Molecular Pathology

The detection of molecular alterations increasingly gain importance for diagnostics, therapeutical decisions and prognosis of dieseases.

Our molecular pathology offers a broad spectrum of methods helping to identify therapeutic relevant molecular alterations.

You are here:

News

15.03.2018: Charité - Universitätsmedizin Berlin Joins Thermo Fisher Scientific's Next-Generation-Sequencing Center of Excellence Program.Link

For questions please contact:

Molecular Pathology
Institute of Pathology
CharitéUniversitätsmedizin Berlin
Charitéplatz 1
10117 Berlin
Germany

+49  30 450 536 035

+49 30 450 536 916